Cyclin-dependent kinase 5, a node protein in diminished tauopathy: A systems biology approach

Frontiers in Aging Neuroscience

Volumn 6, Issue AUG, 2014, Pages

  Castro Alvarez, John Fredy ^a   Uribe Arias, Alejandro ^a   Raigoza, Daniel Mejía ^a   Cardona Gómez, Gloria Patricia ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Alzheimer's disease; CDK5; GSK3 ; phosphotases; Tauopathy

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN; CALCIUM IONOPHORE; N METHYL DEXTRO ASPARTIC ACID; PHOSPHATASE; PHOSPHOTRANSFERASE;

ALZHEIMER DISEASE; ARTICLE; COMPUTER MODEL; EXCITOTOXICITY; HUMAN; MATHEMATICAL MODEL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TAUOPATHY; BRAIN DAMAGE; CALCIUM TRANSPORT; INTRACELLULAR TRANSPORT; MEDICAL SUBJECT HEADINGS; MOLECULE; MYRISTYLATION; NERVE DEGENERATION; NONHUMAN; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW;

EID: 84906235569     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00232     Document Type: Article

References (91)

1. Agarwal-Mawal, A., and Paudel, H.K. (2001). Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J Biol Chem 276, 23712-23718.
2. Ahlijanian, M.K., Barrezueta, N.X., Williams, R.D., Jakowski, A., Kowsz, K.P., Mccarthy, S., Coskran, T., Carlo, A., Seymour, P.A., Burkhardt, J.E., Nelson, R.B., and Mcneish, J.D. (2000). Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A 97, 2910-2915.
3. Anderton, B.H., Brion, J.P., Couck, A.M., Davis, D.R., Gallo, J.M., Hanger, D.P., Ladhani, K., Latimer, D.A., Lewis, C., Lovestone, S., and Et Al. (1995). Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells. Neurobiol Aging 16, 389-397; discussion 398-402.
4. Angelo, M., Plattner, F., and Giese, K.P. (2006). Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory. J Neurochem 99, 353-370.
5. Avila, J., Lucas, J.J., Perez, M., and Hernandez, F. (2004). Role of tau protein in both physiological and pathological conditions. Physiol Rev 84, 361-384.
6. Bennecib, M., Gong, C.X., Grundke-Iqbal, I., and Iqbal, K. (2000). Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485, 87-93.
7. Bertalanffy, L.V. (1969). General system theory: fundations, develoment, applictions.. New york
8. Bhalla, U.S., and Iyengar, R. (1999). Emergent properties of networks of biological signaling pathways. Science 283, 381-387.
9. Bowers, J.M., and Boloure, H. (2001). Computational Modeling of genetic and bioquimical networks Califirnia
10. Cheung, Z.H., and Ip, N.Y. (2007). The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol J.
11. Cicero, S., and Herrup, K. (2005). Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 25, 9658-9668.
12. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hemmings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
13. Cruz, J.C., Tseng, H.C., Goldman, J.A., Shih, H., and Tsai, L.H. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483.
14. Dawson, H.N., Ferreira, A., Eyster, M.V., Ghoshal, N., Binder, L.I., and Vitek, M.P. (2001). Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114, 1179-1187.
15. Dhavan, R., and Tsai, L.H. (2001). A decade of CDK5. Nat Rev Mol Cell Biol 2, 749-759.
16. Fernandez, E., Schiappa, R., Girault, J.A., and Le Novere, N. (2006). DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol 2, e176.
17. Ferrari, A., Hoerndli, F., Baechi, T., Nitsch, R.M., and Gotz, J. (2003). beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 278, 40162-40168.
18. Fu, A.K., Ip, F.C., Fu, W.Y., Cheung, J., Wang, J.H., Yung, W.H., and Ip, N.Y. (2005). Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc Natl Acad Sci U S A 102, 15224-15229.
19. Goll, D.E., Thompson, V.F., Li, H., Wei, W., and Cong, J. (2003). The calpain system. Physiol Rev 83, 731-801.
20. Gong, C.X., Liu, F., Grundke-Iqbal, I., and Iqbal, K. (2005). Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm 112, 813-838.
21. Gotz, J., and Nitsch, R.M. (2001). Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice. Neuroreport 12, 2007-2016.
22. Gotz, J., Schild, A., Hoerndli, F., and Pennanen, L. (2004). Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22, 453-465.
23. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M., and Binder, L.I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913-4917.
24. Hamdane, M., Sambo, A.V., Delobel, P., Begard, S., Violleau, A., Delacourte, A., Bertrand, P., Benavides, J., and Buee, L. (2003). Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem 278, 34026-34034.
25. Hernandez, F., Langa, E., Cuadros, R., Avila, J., and Villanueva, N. (2010). Regulation of GSK3 isoforms by phosphatases PP1 and PP2A. Mol Cell Biochem 344, 211-215.
26. Hernandez, F., Perez, M., De Barreda, E.G., Goni-Oliver, P., and Avila, J. (2008). Tau as a molecular marker of development, aging and neurodegenerative disorders. Curr Aging Sci 1, 56-61.
27. Huang, K.X., and Paudel, H.K. (2000). Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Proc Natl Acad Sci U S A 97, 5824-5829.
28. Ingelsson, M. (2004). Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62, 925-931.
29. Ip, N., and Tsai, L. (2008). Cyclin Dependent Kinase 5 (Cdk5). New York: Springer.
30. Iqbal, K., Alonso Adel, C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.X., Khatoon, S., Li, B., Liu, F., Rahman, A., Tanimukai, H., and Grundke-Iqbal, I. (2005). Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210.
31. Iqbal, K., and Grundke-Iqbal, I. (2005). Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Acta Neuropathol (Berl) 109, 25-31.
32. Iqbal, K., Liu, F., Gong, C.X., Alonso Adel, C., and Grundke-Iqbal, I. (2009). Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118, 53-69.
33. Jellinger, K.A. (2006). Alzheimer 100 - highlights in the history of Alzheimer research. J Neural Transm 113, 1603-1623.
34. Jho, Y.S., Zhulina, E.B., Kim, M.W., and Pincus, P.A. (2010). Monte carlo simulations of tau proteins: effect of phosphorylation. Biophys J 99, 2387-2397.
35. Johnson, G.V., and Stoothoff, W.H. (2004). Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117, 5721-5729.
36. Kawauchi, T., Chihama, K., Nabeshima, Y., and Hoshino, M. (2006). Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 8, 17-26.
37. Kerokoski, P., Suuronen, T., Salminen, A., Soininen, H., and Pirttila, T. (2002). Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not inducetau hyperphosphorylation. Biochem Biophys Res Commun 298, 693-698.
38. Kerokoski, P., Suuronen, T., Salminen, A., Soininen, H., and Pirttila, T. (2004). Both Nmethyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamateinduced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons. Neurosci Lett 368, 181-185.
39. Kesavapany, S., Lau, K.F., Ackerley, S., Banner, S.J., Shemilt, S.J., Cooper, J.D., Leigh, P.N., Shaw, C.E., Mcloughlin, D.M., and Miller, C.C. (2003). Identification of a novel, membrane-associated neuronal kinase, cyclindependent kinase 5/p35-regulated kinase. J Neurosci 23, 4975-4983.
40. Klipp, E., Herwig, A., Kowald, C., and Wierling, H. (2005). Systems Biology in practice. Concepts, Implementation and Aplication Berlin
41. Ko, J., Humbert, S., Bronson, R.T., Takahashi, S., Kulkarni, A.B., Li, E., and Tsai, L.H. (2001). p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21, 6758-6771.
42. Kosik, K.S., and Finch, E.A. (1987). MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum. J Neurosci 7, 3142-3153.
43. Lau, A., and Tymianski, M. (2010). Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 460, 525-542.
44. Lesort, M., Blanchard, C., Yardin, C., Esclaire, F., and Hugon, J. (1997). Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Brain Res Mol Brain Res 45, 127-132.
45. Li, B.S., Ma, W., Jaffe, H., Zheng, Y., Takahashi, S., Zhang, L., Kulkarni, A.B., and Pant, H.C. (2003). Cyclin-dependent kinase-5 is involved in neuregulindependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 278, 35702-35709.
46. Li, Q., and Sudhof, T.C. (2004). Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem 279, 10542-10550.
47. Li, T., Hawkes, C., Qureshi, H.Y., Kar, S., and Paudel, H.K. (2006). Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry 45, 3134-3145.
48. Lindskog, M., Kim, M., Wikstrom, M.A., Blackwell, K.T., and Kotaleski, J.H. (2006). Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS Comput Biol 2, e119.
49. Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C.X. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950.
50. Lopera, F. (2002). La peste de la memoria en Antioquia. Medellín: Editorial Universidad de Antioquia.
51. Mandelkow, E., Von Bergen, M., Biernat, J., and Mandelkow, E.M. (2007). Structural principles of tau and the paired helical filaments of Alzheimer's disease. Brain Pathol 17, 83-90.
52. Mandelkow, E.M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J.R., and Mandelkow, E. (1992). Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314, 315-321.
53. Mandell, J.W., and Banker, G.A. (1996). A spatial gradient of tau protein phosphorylation in nascent axons. J Neurosci 16, 5727-5740.
54. Mora, A., Sabio, G., Risco, A.M., Cuenda, A., Alonso, J.C., Soler, G., and Centeno, F. (2002). Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal 14, 557-562.
55. Morris, M., Maeda, S., Vossel, K., and Mucke, L. (2011). The Many Faces of Tau. Neuron 70, 410-426.
56. Murphy, D.B., and Borisy, G.G. (1975). Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro. Proc Natl Acad Sci U S A 72, 2696-2700.
57. Nakano, T., Doi, T., Yoshimoto, J., and Doya, K. (2010). A kinetic model of dopamineand calcium-dependent striatal synaptic plasticity. PLoS Comput Biol 6, e1000670.
58. Nguyen, C., Nishi, A., Kansy, J.W., Fernandez, J., Hayashi, K., Gillardon, F., Hemmings, H.C., Jr., Nairn, A.C., and Bibb, J.A. (2007). Regulation of protein phosphatase inhibitor-1 by cyclin-dependent kinase 5. J Biol Chem 282, 16511-16520.
59. Niethammer, M., Smith, D.S., Ayala, R., Peng, J., Ko, J., Lee, M.S., Morabito, M., and Tsai, L.H. (2000). NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 28, 697-711.
60. Nikolic, M., Dudek, H., Kwon, Y.T., Ramos, Y.F., and Tsai, L.H. (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10, 816-825.
61. O'hare, M.J., Kushwaha, N., Zhang, Y., Aleyasin, H., Callaghan, S.M., Slack, R.S., Albert, P.R., Vincent, I., and Park, D.S. (2005). Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J Neurosci 25, 8954-8966.
62. Ohshima, T., Ward, J.M., Huh, C.G., Longenecker, G., Veeranna, Pant, H.C., Brady, R.O., Martin, L.J., and Kulkarni, A.B. (1996). Targeted disruption of the cyclindependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93, 11173-11178.
63. Oliver, C.J., and Shenolikar, S. (1998). Physiologic importance of protein phosphatase inhibitors. Front Biosci 3, D961-972.
64. Palsson, B. (2006). Systems biology: properties of reconstructed networks. Cambridge University Press.
65. Pasinetti, G.M., and Hiller, S. (2008). SYSTEMS BIOLOGY IN THE STUDY OF NEUROLOGICAL DISORDERS: FOCUS ON ALZHEIMER'S DISEASE. Alcohol Research and Health 31, 60-65.
66. Patrick, G.N., Zhou, P., Kwon, Y.T., Howley, P.M., and Tsai, L.-H. (1998). p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway.
67. Patrick, G.N., Zukerberg, L., Nikolic, M., Monte, S.D.L., Dikkes, P., and Tsai, L.-H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
68. Peterson, D.W., Ando, D.M., Taketa, D.A., Zhou, H., Dahlquist, F.W., and Lew, J. (2010). No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc Natl Acad Sci U S A 107, 2884-2889.
69. Piedrahita, D., Hernandez, I., Lopez-Tobon, A., Fedorov, D., Obara, B., Manjunath, B.S., Boudreau, R.L., Davidson, B., Laferla, F., Gallego-Gomez, J.C., Kosik, K.S., and Cardona-Gomez, G.P. (2010). Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice. J Neurosci 30, 13966-13976.
70. Plattner, F., Angelo, M., and Giese, K.P. (2006). The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 281,25457-25465.
71. Qi, Z., Miller, G.W., and Voit, E.O. (2010). The internal state of medium spiny neurons varies in response to different input signals. BMC Syst Biol 4, 26
72. Querfurth, H.W., and Laferla, F.M. (2010). Alzheimer's disease. N Engl J Med 362, 329-344.
73. Rashid, T., Banerjee, M., and Nikolic, M. (2001). Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology. J Biol Chem 276, 49043-49052.
74. Resjo, S., Goransson, O., Harndahl, L., Zolnierowicz, S., Manganiello, V., and Degerman, E. (2002). Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes. Cell Signal 14, 231-238.
75. Reynolds, C.H., Betts, J.C., Blackstock, W.P., Nebreda, A.R., and Anderton, B.H. (2000). Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 74, 1587-1595.
76. Rosales, J.L., and Lee, K.Y. (2006). Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 28, 1023-1034.
77. Sengupta, A., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2006). Regulation of phosphorylation of tau by cyclin-dependent kinase 5 and glycogen synthase kinase-3 at substrate level. FEBS Lett 580, 5925-5933.
78. Tashiro, K., Hasegawa, M., Ihara, Y., and Iwatsubo, T. (1997). Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. Neuroreport 8, 2797-2801.
79. Trinczek, B., Biernat, J., Baumann, K., Mandelkow, E.M., and Mandelkow, E. (1995). Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol Biol Cell 6, 1887-1902.
80. V, D. (2009). Centre fot Medical System Biology [Online]. Rotterdam. Available: http://www.cmsb.nl/research/central_nervous_system_domain/alzheimers_disease.php [Accessed 2012]
81. Wang, J.Z., Grundke-Iqbal, I., and Iqbal, K. (2007). Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25, 59-68.
82. Weingarten, M.D., Lockwood, A.H., Hwo, S.Y., and Kirschner, M.W. (1975). A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72, 1858-1862.
83. Wen, Y., Planel, E., Herman, M., Figueroa, H.Y., Wang, L., Liu, L., Lau, L.F., Yu, W.H., and Duff, K.E. (2008). Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci 28, 2624-2632.
84. Wen, Y., Yang, S.H., Liu, R., Perez, E.J., Brun-Zinkernagel, A.M., Koulen, P., and Simpkins, J.W. (2007). Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 1772, 473-483.
85. Witman, G.B., Cleveland, D.W., Weingarten, M.D., and Kirschner, M.W. (1976). Tubulin requires tau for growth onto microtubule initiating sites. Proc Natl Acad Sci U S A 73, 4070-4074.
86. Yang, R.F., Maria. Dolile Iii, Peter (2014). "Systems Biology," in Modelling Methodology for Physiology and Medicine, ed. Elsevier. 2 ed: Modelling Methodology for Physiology and Medicine (Second Edition)), 159-187.
87. Yu, Y., Run, X., Liang, Z., Li, Y., Liu, F., Liu, Y., Iqbal, K., Grundke-Iqbal, I., andGong, C.X. (2009). Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neurochem 108, 1480-1494.
88. Zheng, M., Leung, C.L., and Liem, R.K. (1998). Region-specific expression of cyclindependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J Neurobiol 35, 141-159.
89. Zheng, Y.L., Kesavapany, S., Gravell, M., Hamilton, R.S., Schubert, M., Amin, N., Albers, W., Grant, P., and Pant, H.C. (2005). A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. Embo J 24, 209-220.
90. Zheng, Y.L., Li, B.S., Amin, N.D., Albers, W., and Pant, H.C. (2002). A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells. Eur J Biochem 269, 4427-4434.
91. Zheng, Y.L., Li, B.S., Kanungo, J., Kesavapany, S., Amin, N., Grant, P., and Pant, H.C. (2007). Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell 18, 404-413.